MarketWatch: Health Round-up
Pages: 59
Publisher: Datamonitor
Date Published: June 2006
Format: PDF
Price: $400
Overview
Datamonitor’s MarketWatch Health Round-up is a one-stop news shop for time-pressed executives. It provides monthly insight into the key events in the Healthcare industry. The report contains the latest news, analysis and opinion, covering all the month’s major issues and events in R&D, regulatory and licensing in the Healthcare industry.
Table of Contents
In this month’s MarketWatch…
Pharmaceutical Company Round-up
Page 3
Cancer Update
Page 4 – News Round-up
Page 7 – Opinion: NeoPharm: more promising survival data for cintredekin besudotox…
Page 8 – Opinion: Genitope: difficult road ahead for MyVax…
Page 9 – Feature Analysis: Adult acute leukemia: demand for innovative drugs that prolong survival…
Cardiovascular Update
Page 12 – News Round-up
Page 15 – Opinion: CV Therapeutics: Ranexa set to underwhelm again…
Page 16 – Opinion: Novartis: Sandoz drives profit surge…
Page 16 – Opinion: The Medicines Company: a clot on the horizon…
Page 17 – Opinion: Myriad Genetics: clogging up the anti-thrombin drug race?
CNS Update
Page 19 – News Round-up
Page 22 – Opinion: Acadia: a novel insomnia treatment is stirring…
Page 23 – Opinion: UCB: IV Keppra gets EU regulatory nod…
Page 23 – Opinion: Cyberonics: depressing times?
Page 24 – Opinion: Vernalis/Endo: gain in menstrual migraine…
IDI Update
Page 26 – News Round-up
Page 29 – Opinion: Altana: putting the feelers out for a suitable partner…
Page 30 – Opinion: ImmunoMedics/UCB: looking to lupus…
Page 30 – Opinion: Asthmatx: a new approach to asthma…
Page 31 – Opinion: SkyePharma: Flutiform back on track…
Page 32 – Opinion: Pfizer/Nektar: Exubera to enjoy strong mid-term growth…
Page 33 – Opinion: Diabetes: Pfizer holds its breath…
Infectious Diseases Update
Page 34 – News Round-up
Page 37 – Opinion: MedImmune: CAIV-T results not to be sneezed at…
Page 38 – Feature Analysis: Pandemic threat reignites influenza vaccine market…
Company Spotlight
Page 41 – Bayer AG
Biotechnology Update
Page 47 – Biotech News Round-up
Page 50 – Opinion: Biogenerics: US to finally follow EU’s lead?
Page 51 – Opinion: Merck & Co: treading the biotech path…
Company Spotlight
Page 52 – Cephalon
Index
Page 58 – Pharma companies
Page 58 – Biotech companies
Page 59 – Key drugs
